These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 18076912

  • 1. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [Abstract] [Full Text] [Related]

  • 2. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 3. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG.
    Clin Cancer Res; 2003 Jul 15; 9(7):2673-7. PubMed ID: 12855646
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 6. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV, Guo Z, Epstein JI, Sidransky D.
    J Urol; 2003 Mar 29; 169(3):1138-42. PubMed ID: 12576869
    [Abstract] [Full Text] [Related]

  • 7. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D.
    Clin Cancer Res; 2001 Sep 29; 7(9):2727-30. PubMed ID: 11555585
    [Abstract] [Full Text] [Related]

  • 8. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML, Nakayama M, Lee SM, De Marzo AM, Nelson WG.
    Urology; 2004 Feb 29; 63(2):414-8. PubMed ID: 14972513
    [Abstract] [Full Text] [Related]

  • 9. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O.
    Clin Cancer Res; 2007 Mar 15; 13(6):1720-5. PubMed ID: 17363525
    [Abstract] [Full Text] [Related]

  • 10. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.
    J Cell Biochem; 2004 Feb 15; 91(3):540-52. PubMed ID: 14755684
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
    Crocitto LE, Korns D, Kretzner L, Shevchuk T, Blair SL, Wilson TG, Ramin SA, Kawachi MH, Smith SS.
    Urology; 2004 Oct 15; 64(4):821-5. PubMed ID: 15491741
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

  • 13. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
    Rogers CG, Gonzalgo ML, Yan G, Bastian PJ, Chan DY, Nelson WG, Pavlovich CP.
    J Urol; 2006 Nov 01; 176(5):2280-4. PubMed ID: 17070312
    [Abstract] [Full Text] [Related]

  • 14. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R, Jerónimo C.
    Eur Urol; 2004 Nov 01; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [Abstract] [Full Text] [Related]

  • 15. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C, Krause H, Müller M, Heicappell R, Schrader M, Sachsinger J, Miller K.
    Cancer Res; 2000 Nov 01; 60(21):5941-5. PubMed ID: 11085508
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M.
    Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910
    [Abstract] [Full Text] [Related]

  • 17. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 18. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
    Payne SR, Serth J, Schostak M, Kamradt J, Strauss A, Thelen P, Model F, Day JK, Liebenberg V, Morotti A, Yamamura S, Lograsso J, Sledziewski A, Semjonow A.
    Prostate; 2009 Sep 01; 69(12):1257-69. PubMed ID: 19459176
    [Abstract] [Full Text] [Related]

  • 19. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 20. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
    Eilers T, Machtens S, Tezval H, Blaue C, Lichtinghagen R, Hagemann J, Jonas U, Serth J.
    Prostate; 2007 May 15; 67(7):757-63. PubMed ID: 17373715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.